Parameter | Sex | Reference range | Group | Ingestion period | Follow-up period | |||
---|---|---|---|---|---|---|---|---|
0 w | 4 w | 8 w | 12 w | 16 w | ||||
TP (g/dL) | 6.5-8.2 | A | 7.30 (0.03) | 7.27 (0.04) | 7.23 (0.03)* | 7.26 (0.03) | 7.30 (0.03) | |
P | 7.29 (0.03) | 7.22 (0.03)* | 7.28 (0.04) | 7.28 (0.04) | 7.31 (0.04) | |||
Alb (g/dL) | 3.7-5.5 | A | 4.46 (0.02) | 4.43 (0.02) | 4.42 (0.02)* | 4.43 (0.02)* | 4.48 (0.02) | |
P | 4.50 (0.02) | 4.46 (0.02)* | 4.48 (0.02) | 4.48 (0.03) | 4.54 (0.02)* | |||
T-Bil (mg/dL) | 0.3-1.2 | A | 0.70 (0.03) | 0.72 (0.03) | 0.68 (0.03) | 0.68 (0.03) | 0.68 (0.03) | |
P | 0.74 (0.03) | 0.72 (0.03) | 0.69 (0.03) | 0.71 (0.03) | 0.67 (0.03)** | |||
AST (U/L) | 10-40 | A | 21.1 (0.6) | 20.5 (0.6)* | 21.2 (0.7) | 21.5 (0.9) | 22.5 (0.8)* | |
P | 20.9 (0.6) | 20.7 (0.7) | 21.3 (0.9) | 21.4 (0.8) | 21.4 (0.5) | |||
ALT (U/L) | 5-45 | A | 23.7 (1.3) | 22.0 (1.3)** | 23.0 (1.3) | 23.3 (1.6) | 25.0 (1.7) | |
P | 22.2 (1.4) | 21.0 (1.1) | 24.1 (1.8) | 23.5 (1.5) | 22.5 (1.0) | |||
LDH (U/L) | 120-245 | A | 172.4 (2.5) | 178.9 (2.8)** | 174.9 (2.9) | 179.1 (3.5)** | 178.8 (3.7)* | |
P | 175.5 (3.6) | 179.3 (3.1) | 175.6 (3.3) | 173.3 (2.7) | 174.1 (2.8) | |||
ALP (U/L) | 104-338 | A | 199.4 (5.3) | 199.7 (5.4) | 198.4 (5.3) | 197.8 (5.1) | 200.7 (5.4) | |
P | 190.2 (5.5) | 187.7 (5.5) | 193.6 (5.6) | 195.6 (5.9)* | 197.5 (6.0)** | |||
γ-GTP (U/L) | M | ≤79 | A | 37.7 (3.8) | 36.1 (3.6) | 37.6 (4.0) | 37.0 (4.0) | 38.9 (3.9) |
P | 39.7 (5.2) | 39.6 (4.3) | 43.2 (5.6) | 41.0 (5.1) | 40.7 (3.8) | |||
F | ≤48 | A | 24.7 (2.2)# | 23.2 (1.7) | 24.8 (2.3) | 23.8 (2.0) | 26.8 (2.5) | |
P | 19.7 (1.3) | 19.2 (1.2) | 21.5 (1.6)* | 20.7 (1.4) | 21.6 (2.0) |